Penmenvy (Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine 10 MCG / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen 50 MCG / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen 50 MCG / Neisseria meningitidis serogroup B recombinant NADA fusion protein antigen 50 MCG / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle 25 MCG / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 5 MCG / Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine 5 MCG / Neisseria meningitidis serogroup Y oligos
RxCUI
2705467
RxNorm name
Penmenvy (Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine 10 MCG / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen 50 MCG / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen 50 MCG / Neisseria meningitidis serogroup B recombinant NADA fusion protein antigen 50 MCG / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle 25 MCG / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 5 MCG / Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine 5 MCG / Neisseria meningitidis serogroup Y oligos
Display name
Penmenvy (Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine 10 MCG / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen 50 MCG / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen 50 MCG / Neisseria meningitidis serogroup B recombinant NADA fusion protein antigen 50 MCG / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle 25 MCG / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 5 MCG / Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine 5 MCG / Neisseria meningitidis serogroup Y oligos
Full name
Penmenvy (Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine 10 MCG / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen 50 MCG / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen 50 MCG / Neisseria meningitidis serogroup B recombinant NADA fusion protein antigen 50 MCG / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle 25 MCG / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 5 MCG / Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine 5 MCG / Neisseria meningitidis serogroup Y oligos
Penmenvy (Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine 10 MCG / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen 50 MCG / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen 50 MCG / Neisseria meningitidis serogroup B recombinant NADA fusion protein antigen 50 MCG / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle 25 MCG / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 5 MCG / Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine 5 MCG / Neisseria meningitidis serogroup Y oligos
SY
3
These highlights do not include all the information needed to use PENMENVY safely and effectively. See full prescribing information for PENMENVY. PENMENVY (Meningococcal Groups A, B, C, W, and Y Vaccine) for injectable suspension, for intramuscular use Initial U.S. Approval: 2025
These highlights do not include all the information needed to use PENMENVY safely and effectively. See full prescribing information for PENMENVY. PENMENVY (Meningococcal Groups A, B, C, W, and Y Vaccine) for injectable suspension, for intramuscular use Initial U.S. Approval: 2025
0.5 ML Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogroup B recombinant NADA fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle 0.05 MG/ML / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML / Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML / Neisseria meningi
SBD
3
These highlights do not include all the information needed to use PENMENVY safely and effectively. See full prescribing information for PENMENVY. PENMENVY (Meningococcal Groups A, B, C, W, and Y Vaccine) for injectable suspension, for intramuscular use Initial U.S. Approval: 2025